Tag: pharmaceuticals
Anatara to begin clinical trial of gastro medicine with ethics approval
Pharmaceuticals manufacturer and developer Anatara Lifesciences Ltd (ASX:ANR) announced today that it has received Human Research Ethics Committee (HREC) approval to begin clinical trials...
Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia
Media Release
The Bridgewest Group, a premier private investment company that focuses on disrupting industries through innovation today announced its subsidiary's purchase of Pfizer's biologics...
Healthcare products, pharmaceuticals, and agricultural innovation could be Australia’s domestic manufacturing future says UNSW...
Media Release
Business leaders, community groups and politicians across the politician spectrum have called for Australia to build up its domestic manufacturing capability during the Coronavirus pandemic.
With...
APCO celebrates sustainable packaging leaders at annual awards ceremony
Media Release
The Australian businesses leading the way in sustainable packaging design and innovation were recognised last night at the annual Australian Packaging Covenant Organisation...
GSK Australia opens new $8m pilot vaccine plant in Victoria (VIDEO)
Leading research-based pharmaceutical and healthcare company GSK Australia has opened a new vaccine plant in Boronia, Victoria.
The new pilot plant is the result of...
AHMADA voices support for stricter country of origin regulations
Ultra Mix, a Melbourne-based manufacturer of oral and topical products and a member of the Australian Health Manufacturers and Development Association (AHMADA), has raised...
140 jobs to go as Pfizer Australia announces shut down of Sydney plant in...
Pharmaceutical company Pfizer will close its Sydney manufacturing plant in 2015, taking with it about 140 jobs.
According to the AAP report published via The...
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
